Is Ro Weight Loss FDA Approved? (Verified 2026 Medication List)
Every medication currently on Ro's Body weight-loss menu, its exact FDA approval date, the real all-in monthly cost, and the one thing to confirm before you pay.
Published: · Last reviewed:
Online assessment. Ro's terms: if no medication is prescribed, you're refunded and not enrolled.
The Short Answer
Is Ro weight loss FDA approved?
Every medication currently on Ro's Body weight-loss menu is FDA-approved: Wegovy pen, Wegovy HD pen (approved March 19, 2026), Wegovy pill (approved December 2025), Zepbound pen, Zepbound KwikPen, Zepbound vials, and Foundayo (approved April 1, 2026). Ro-affiliated providers may also prescribe Ozempic off-label for weight loss — Ozempic is FDA-approved for type 2 diabetes, not weight management.
Technically, "Ro" itself is not FDA-approved — because the FDA approves drugs, not telehealth companies. So the more useful answer is: the medications you'd actually get from Ro are.
One thing worth checking in your own checkout: Ro's general Terms of Use still mention the possibility of compounded medication during national drug shortages. Ro's current Body weight-loss lineup is FDA-approved brand names only, but confirm the exact drug name you're prescribed before you pay if FDA-approved-only is your hard line.
If you want the full picture — the FDA approval matrix, the real all-in monthly cost, where Ro fits in the post-March-2026 regulatory landscape, what's not covered — keep reading. We built the rest of this page so you'd have one place to verify it and walk away certain.
FDA-Status Snapshot
Every weight-loss medication on Ro Body, the FDA status, and what we verified:
| Medication | FDA-approved for weight loss? | Approval date |
|---|---|---|
| Wegovy pen (semaglutide 0.25–2.4 mg) | ✅ Yes | June 4, 2021 |
| Wegovy HD pen (semaglutide 7.2 mg) | ✅ Yes | March 19, 2026 |
| Wegovy pill (oral semaglutide 25 mg) | ✅ Yes | December 2025 |
| Zepbound pen, KwikPen, vials (tirzepatide) | ✅ Yes | November 2023 |
| Foundayo (orforglipron) | ✅ Yes | April 1, 2026 |
| Ozempic (semaglutide) | ⚠️ FDA-approved for type 2 diabetes, not weight loss; prescribed off-label | December 2017 (T2D) |
This page verifies FDA-status, pricing, and policy claims. It is not a medical evaluation. GLP-1 treatment requires review by a licensed healthcare provider.
What We Actually Verified
| What we checked | When | Source |
|---|---|---|
| Ro membership pricing ($39/$149/$74 annual) | May 15, 2026 | ro.co/weight-loss/pricing/ |
| Medication cash prices (Foundayo, Wegovy pen, Wegovy pill, Wegovy HD, Zepbound) | May 15, 2026 | Ro medication pages + NovoCare price guide |
| FDA approval dates | May 15, 2026 | FDA press releases at fda.gov |
| Whether Ro was on the March 3, 2026 FDA warning letter list | May 15, 2026 | FDA press release + independent enforcement coverage |
| Cancellation, refund, and government-insurance terms | May 15, 2026 | ro.co/terms-of-use, ro.co/weight-loss/insurance |
What we did not verify ourselves: the live signup flow on the day you're reading this, day-of state availability, or pharmacy partner audits. Clinical and pricing decisions belong to Ro and Ro-affiliated providers.
We re-check this page monthly through Q2 2026 (Foundayo and Wegovy HD are still rolling out), then quarterly. Spot something stale? Email corrections@therxindex.com and we'll update within 48 hours.
The Full FDA Approval Matrix (Verified May 15, 2026)
Every weight-loss medication Ro prescribes, the approval details, and the current Ro cash price — assembled in one place so you don't have to open six tabs to verify it.
| Medication | Approval date | Indication | Form | Manufacturer | Current Ro cash price |
|---|---|---|---|---|---|
| Wegovy pen semaglutide 0.25–2.4 mg | June 4, 2021 | Chronic weight management; cardiovascular risk reduction in adults with CVD and obesity | Weekly injection | Novo Nordisk | $199/mo first 2 months for new patients on 0.25/0.5 mg (intro through June 30, 2026), then $349/mo |
| Wegovy HD pen semaglutide 7.2 mg | March 19, 2026 ★ NEW | Adults already tolerating 2.4 mg ≥4 weeks who need additional weight reduction | Weekly injection (single-dose pen) | Novo Nordisk | $399/mo cash. Prepay: $329/mo (3-mo plan), $299/mo (6-mo), $249/mo (annual) |
| Wegovy pill oral semaglutide 25 mg | December 2025 ★ NEW | Chronic weight management | Daily oral tablet (fasted) | Novo Nordisk | $149/mo (1.5 mg & 4 mg); $299/mo (9 mg & 25 mg) |
| Zepbound pen tirzepatide | November 2023 | Chronic weight management; moderate-to-severe OSA in obese adults | Weekly injection | Eli Lilly | Insurance route; copays vary by plan |
| Zepbound KwikPen tirzepatide | November 2023 | Chronic weight management | Weekly injection (4-dose pen) | Eli Lilly | $299/mo (2.5 mg), $399/mo (5 mg), $449/mo (7.5–15 mg). Miss refill check-in within 45 days: $499–$699/mo. |
| Zepbound vials tirzepatide | November 2023 | Chronic weight management | Weekly injection (manual draw) | Eli Lilly | $299/mo (2.5 mg) – $449/mo (7.5–15 mg) cash |
| Foundayo orforglipron | April 1, 2026 ★ NEWEST | Chronic weight management | Daily oral tablet (any time, with or without food) | Eli Lilly | $149/mo (0.8 mg), $199/mo (2.5 mg), $299/mo (5.5–17.2 mg). 14.5/17.2 mg → $349/mo if refill check-in missed. |
| Ozempic semaglutide — off-label | December 2017 (T2D) | Type 2 diabetes (FDA-approved); weight loss off-label only | Weekly injection | Novo Nordisk | ~$900–$1,100/mo cash (typically via insurance) |
Sources: FDA press releases (March 19, 2026 Wegovy HD; April 1, 2026 Foundayo; December 2025 Wegovy pill; June 4, 2021 Wegovy; November 2023 Zepbound; December 2017 Ozempic). Novo Nordisk and Eli Lilly product labels at Drugs@FDA. Ro pricing pages verified May 15, 2026. U.S. News health review for Ozempic cash range.
Is Ro Itself FDA-Approved? (The Question Behind Your Question)
"FDA-approved" is a label that goes on a specific drug, formulation, and indication — after the FDA reviews clinical trials and confirms it's safe and effective for that specific use. The FDA does not put that label on companies, apps, websites, or memberships. It can't. That's not what the label means.
Which means Ro is not "FDA-approved" — and neither is Hims, Eden, MEDVi, Sesame, your doctor's office, or the pharmacy at CVS. None of them are. What matters is whether the medicine you actually take has been FDA-reviewed.
For Ro's weight-loss program, the answer to that is yes. Every GLP-1 medication on Ro's current Body lineup is an FDA-approved brand-name drug — made by Novo Nordisk (Wegovy in all forms, Ozempic) or Eli Lilly (Zepbound in all forms, Foundayo). Ro's pricing page openly states that its cash-pay medication prices match LillyDirect, NovoCare, and TrumpRx, and Ro integrates directly with NovoCare and LillyDirect for shipping where applicable.
One honest wrinkle worth naming
Ro does sell some compounded products in non-weight-loss categories. Products like Sparks and Daily Rise Gummies (sexual health) are compounded medications, and Ro openly discloses on its own site that these are not FDA-approved and do not undergo FDA safety, effectiveness, or manufacturing review.
Why are we telling you this on a weight-loss page? Because if you Google around, you'll find people lumping all of Ro's product lines together. The accurate picture: for weight loss specifically, Ro's current Body program lineup is FDA-approved brand-name GLP-1s. The compounded products are in different categories and not part of the Ro Body program.
Also worth knowing: Ro's general Terms of Use (last revised April 2, 2026) still say members may be prescribed compounded medication during national drug shortages. That language was operationally relevant in 2023–2024 when the FDA had declared shortages of semaglutide and tirzepatide. Those shortages were resolved in 2024–2025, and Ro's current public Body lineup is FDA-approved brand names. The cleanest move is to confirm the exact drug name before you complete checkout.
Every Weight-Loss Medication Ro Prescribes (The Detailed Breakdown)
Wegovy pen (semaglutide injection)
FDA-approved for chronic weight management in adults with obesity, or overweight plus at least one weight-related condition. Also FDA-approved for cardiovascular risk reduction in adults with cardiovascular disease and obesity or overweight.
Taken once weekly as a subcutaneous injection. This is the original FDA-approved semaglutide for weight management — at the higher 2.4 mg maintenance dose. In the STEP 1 trial published in the New England Journal of Medicine, participants lost an average of about 15% of body weight at 68 weeks on the 2.4 mg dose.
Wegovy HD pen (semaglutide 7.2 mg) — the new higher dose
FDA-approved under the new Commissioner's National Priority Voucher pilot program just 54 days after Novo Nordisk filed the application. Wegovy HD is meant for adults who have already taken the standard 2.4 mg dose for at least 4 weeks and still need more weight reduction.
In the STEP UP trial (about 1,400 adults with obesity), semaglutide 7.2 mg produced average weight loss of close to 19% body weight over 72 weeks — with about one in three participants losing 25% or more. That's the highest weight loss recorded for any Wegovy injection.
Novo Nordisk launched Wegovy HD nationwide in April 2026 through pharmacies, NovoCare, and select telehealth providers including Ro.
Wegovy pill (oral semaglutide 25 mg)
The first FDA-approved oral GLP-1 for weight loss. Novo Nordisk launched it nationwide in January 2026. Within roughly 10 weeks of launch, an estimated 400,000 Americans were already taking it.
In its pivotal trial, participants taking the 25 mg dose lost about 16.6% of body weight (trial completers) over 64 weeks — close to the injectable Wegovy result.
Zepbound — pen, KwikPen, and vials (tirzepatide)
FDA-approved November 2023 for chronic weight management. Also FDA-approved (December 2024) for moderate-to-severe obstructive sleep apnea in adults with obesity.
Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates two appetite-regulating hormones, not one. In the SURMOUNT-1 trial, participants lost an average of 18–21% of body weight over 72 weeks at the higher doses — roughly 5–6 percentage points more than semaglutide alone.
Ro offers three formats of the same FDA-approved medication:
- ▸Zepbound pen (autoinjector): primarily the insurance-covered route on Ro. Copays vary by plan.
- ▸Zepbound KwikPen (4-dose pen) cash-pay: $299/mo for 2.5 mg, $399/mo for 5 mg, $449/mo for 7.5–15 mg. Miss refill check-in within 45 days: $499/mo at 7.5 mg, $699/mo at 10–15 mg.
- ▸Zepbound vials (manual draw): most affordable Zepbound cash option. $299/mo (2.5 mg) through $449/mo (maintenance doses).
Foundayo (orforglipron) — the newest daily oral GLP-1
Foundayo (the brand name for orforglipron, made by Eli Lilly) is the first non-peptide oral GLP-1 for weight management.
In clinical trials of adults without diabetes, people taking Foundayo lost about 7.5–11.2% of body weight over 72 weeks. A bit less than the injectables, with the easiest dosing.
See our full Foundayo guide for complete trial data and eligibility criteria.
Ozempic (semaglutide) — FDA-approved, but for diabetes
FDA-approved December 2017 for adults with type 2 diabetes. Ozempic is not FDA-approved for weight loss.
Ozempic contains the same active ingredient as Wegovy (semaglutide), just at lower doses and with a different FDA-approved indication. A licensed provider can legally prescribe Ozempic off-label for weight loss when they judge it clinically appropriate — and Ro-affiliated providers do this. Off-label prescribing is legal and well-established in US medicine.
Does Ro Prescribe Compounded Semaglutide for Weight Loss?
Ro's current public pricing page lists FDA-approved brand-name GLP-1s only for weight loss. Ro's pricing page explicitly states Ro offers FDA-approved GLP-1s at cash-pay prices matching LillyDirect, NovoCare, and TrumpRx. The U.S. News 2026 review of Ro likewise states Ro only offers FDA-approved brand-name GLP-1 medications.
The "compounded medication during shortages" language in Ro's general terms is the legal contingency clause from when the FDA had declared semaglutide and tirzepatide shortages (2022–2024). Those shortages were officially resolved. Ro made a strategic call months before the March 2026 FDA crackdown to anchor its weight-loss program to FDA-approved brand names — that's why Ro's pricing is structured around NovoCare and LillyDirect integrations, not around 503B compounding pharmacy partnerships.
If you want to be absolutely certain on your specific prescription:
- 1After Ro's clinical assessment, the medication recommendation should name a specific FDA-approved brand: Wegovy, Wegovy HD, Wegovy pill, Zepbound, Foundayo, or Ozempic.
- 2If you ever see "compounded semaglutide" or "compounded tirzepatide" in your checkout, that's a different lane than what Ro's current Body program advertises — pause and ask why.
- 3Most readers will see one of the FDA-approved brand names. That's the path Ro is built around in 2026.
How Ro Stayed Off the March 2026 FDA Warning Letter List
The primary violations the FDA cited were not "selling compounded GLP-1s" in the abstract — they were false or misleading marketing claims about compounded products, including claims implying these compounded versions were the same as FDA-approved Wegovy, Ozempic, Mounjaro, or Zepbound, and marketing that obscured which pharmacy actually compounded the drug.
Industry coverage from MM&M and pharma trade publications confirmed that the 30 recipients were primarily small-to-midsize telehealth firms relying heavily on performance marketing and affiliate channels. The major digital pharmacies that sell FDA-approved GLP-1s — including Ro and Hims & Hers — were not on this March 3 list.
The practical translation: if avoiding the compounded-GLP-1 regulatory uncertainty matters — because you don't want to be told in 4 months that your medication source got shut down or your provider got a warning letter — Ro's structural position is built for exactly that. The medication you'd get is brand-name, FDA-approved, and shipped from manufacturer-direct pharmacy partners.
Start with Ro's FDA-approved GLP-1 path →How Much Does Ro Weight Loss Cost in 2026? (The Real Math)
The single most common complaint thread in BBB reports and Reddit discussions about Ro is people who didn't realize the membership and the medication were billed separately. Here's the actual math in one place.
The all-in monthly cost table
| Medication path | Medication price | Membership | First-month all-in | Ongoing monthly all-in | Annual-plan monthly |
|---|---|---|---|---|---|
| Wegovy pill | $149 first mo (1.5/4 mg) → $149–$299 ongoing | $39 first / $149 ongoing / $74 annual | $188 | $298–$448 | $223–$373 |
| Foundayo | $149 first mo (0.8 mg) → $149–$299 ongoing | Same | $188 | $298–$448 | $223–$373 |
| Wegovy pen | $199 first 2 mo → $349 ongoing | Same | $238 | $498 | $423 |
| Wegovy HD pen | $399/mo cash → $249/mo annual prepay | Same | $438 | $548 | $323 |
| Zepbound KwikPen (with check-in) | $299–$449 by dose | Same | $338–$488 | $448–$598 | $373–$523 |
| Zepbound vials | $299–$449 by dose | Same | $338–$488 | $448–$598 | $373–$523 |
| Ozempic (off-label, cash) | $900–$1,100 | Same | $939–$1,139 | $1,049–$1,249 | $974–$1,174 |
| Insurance route (any covered med) | Medication copay (varies) | Same | $39 + copay | $149 + copay | $74 + copay |
Sources: Ro pricing page, individual Ro medication pages (Foundayo, Wegovy HD, Wegovy pill, Wegovy cost), and NovoCare price guide. Verified May 15, 2026.
One honest tradeoff
Ro is not the cheapest way to get FDA-approved GLP-1 medication. If you already have a doctor who'll prescribe Wegovy or Zepbound and handle your insurance prior authorization, the $149/month membership is an extra layer of cost. You can get the same Wegovy pill from NovoCare directly, or the same Zepbound vials from LillyDirect directly, at the same medication price — without paying Ro.
If lowest-medication-price-only is your single priority, manufacturer-direct is cheaper. Ro's value is the clinical layer: insurance concierge handling prior authorization paperwork, monthly provider check-ins, included Quest lab testing, unlimited messaging, and a coordinated program. For most people who don't already have a clinician managing weight-loss treatment, the membership fee is essentially paying for a clinician.
Does Ro Take Insurance for GLP-1 Medications?
What Ro's insurance concierge actually does
For commercial insurance (most employer-sponsored plans, individual marketplace plans):
- 1You complete Ro's online assessment.
- 2A Ro-affiliated provider determines if treatment is appropriate.
- 3The insurance concierge checks whether your plan covers GLP-1s for weight management.
- 4If a prior authorization is required, the concierge submits the paperwork on your behalf.
- 5If denied, the concierge helps with the appeal.
Ro says the insurance-coverage process typically takes about 2–3 weeks. Insurer prior-authorization review can take about 2–9 days; denials and appeals can take longer and vary by insurer.
Government insurance — the precise picture
| Plan type | Can you join Ro Body? | Does Ro coordinate coverage? |
|---|---|---|
| Commercial insurance (employer/marketplace) | Yes | Yes — insurance concierge handles PA |
| Medicare / Medicare Supplement | Yes (pay cash for medication) | No |
| TRICARE | Yes (pay cash for medication) | No |
| Federal Employees Health Benefits (FEHB) | Yes | Yes — insurance concierge available |
| Medicaid | No — cannot join Ro Body | N/A |
| Most other government-funded plans | No | N/A |
If you have Medicaid or another government-funded plan that disqualifies you from Ro Body, the practical alternatives for FDA-approved GLP-1 access are paying directly through NovoCare or LillyDirect, or comparing Sesame Care — which offers individual provider visits for branded GLP-1s with broader provider choice.
What Happens If You Cancel Ro Body?
Membership cancellation
Cancel through your Ro account (Plan section) or by emailing Ro support. Cancellation should be initiated at least 48 hours before your renewal date so the next charge doesn't process. Once a membership fee has been billed for a period, it's non-refundable for that period — you keep access through the end of the billing cycle.
Medication refunds
Prescription medication generally cannot be returned for a refund once it has shipped. Federal regulations prohibit returning dispensed medication to pharmacy inventory for reuse, except in cases of pharmacy error. If you cancel mid-month after your medication shipped, the medication stays with you and the fee stays paid.
The cleanest cancel sequence
- 1Start on the monthly plan ($39 first month, then $149/mo) — not the annual prepay ($74/mo).
- 2After your first cycle, you'll know whether the medication and program are working for you.
- 3If you want to continue, switching to annual prepay later saves money.
- 4If you want to cancel, do it at least 48 hours before your next renewal date.
The annual prepay is the cheaper-per-month rate but locks in a full year up front. Only go annual once you're confident.
Before You Click "Check Eligibility": The 7-Question Verification Checklist
Use this checklist on Ro. Use it on any provider. Copy it into your notes before you start the assessment — once you're inside the checkout flow with your card saved, it's much harder to slow down and verify.
What exact medication name am I being prescribed?
It should be one of: Wegovy (pen, HD pen, or pill), Zepbound (pen, KwikPen, or vials), Foundayo, or Ozempic. If you see "compounded semaglutide" or "compounded tirzepatide" anywhere in your Ro checkout, pause and ask why — Ro's current Body program advertises FDA-approved brand names only.
Is it FDA-approved for weight loss specifically?
Wegovy (all forms), Zepbound (all forms), and Foundayo are. Ozempic is FDA-approved for type 2 diabetes and prescribed off-label for weight loss — a different category.
What's my actual first-month total — membership plus medication?
Use our cost table above. The $39 in Ro's ads is the membership only.
What's my ongoing monthly total after the first month?
Membership goes to $149/mo (or $74/mo annual prepay). Some medications also step up after the intro promo.
Are there refill check-in conditions on my dose?
Zepbound KwikPen 7.5–15 mg and Foundayo 14.5/17.2 mg require completing refill check-ins within 45 days of last delivery to keep the discounted price.
What happens if my insurance denies prior authorization?
Ro will offer cash-pay options. Make sure you'd be willing to pay those before approving the next charge.
Can I cancel before my next renewal?
Confirm the cancellation method (account dashboard or email) and the 48-hour window.
Who Ro Is Best For (And Who Should Skip It)
✓ Ro is a strong fit if you…
- ▸Want FDA-approved brand-name GLP-1s (Wegovy in any form, Zepbound in any form, Foundayo) — not compounded.
- ▸Have commercial insurance and want help with prior authorization.
- ▸Don't have a doctor who'll prescribe weight-loss meds, or your doctor has no experience with GLP-1 prior authorization.
- ▸Want monthly provider check-ins, unlimited messaging, lab testing where ordered, and a structured program.
- ▸Want access to the new Wegovy HD or Foundayo, which Ro carries.
- ▸Prefer a mainstream telehealth experience with manufacturer-direct medication sourcing.
✗ Ro is the wrong fit if you…
- ▸Have Medicaid — Ro says these users cannot join Ro Body.
- ▸Want the absolute lowest medication cost and would consider compounded GLP-1s.
- ▸Already have a doctor prescribing for you. Going through NovoCare for Wegovy or LillyDirect for Zepbound saves the $149/month membership.
- ▸Specifically want Costco-member pricing on Wegovy/Ozempic or want to pick your own provider for branded GLP-1s.
- ▸Need urgent or complex in-person medical management.
Not sure which FDA-approved GLP-1 program is right for you?
If you're somewhere in the middle — for example, you're on Sesame Care's radar for provider flexibility, or you want to compare pricing before committing — compare your options before clicking through.
What Ro Members Say (And How to Read Testimonials)
Ro openly identifies its on-site testimonials as paid. A common theme in the quoted reviews is surprise at how much the insurance concierge helped. One paid Ro member said simply: "I was not expecting insurance help."
Outside Ro's site, the 2026 U.S. News health review describes Ro as a legitimate, established telehealth platform that prescribes FDA-approved brand-name GLP-1 medications through U.S.-licensed providers.
How We Verified This Page
Independent verification matters more than ever in GLP-1 telehealth. Here's exactly what we did and didn't do.
What we verified ✓
- ▸Every FDA approval date against official FDA press releases and product labels at Drugs@FDA (fda.gov).
- ▸Current Ro membership pricing at ro.co/weight-loss/pricing/ on May 15, 2026.
- ▸Current medication cash-pay pricing at Ro's individual medication pages and the NovoCare price guide PDF.
- ▸Ro's absence from the FDA's March 3, 2026 list of 30 telehealth warning-letter recipients, confirmed against the FDA press release and independent industry coverage (MM&M, Pharmaceutical Technology, Foley & Lardner LLP).
- ▸Ro's Terms of Use language on cancellation, refunds, and compounded medication at ro.co/terms-of-use/.
- ▸Ro's insurance, government-plan, and FEHB eligibility language at ro.co/weight-loss/insurance/.
- ▸Clinical trial weight-loss percentages against published trial data (STEP UP, STEP 1, SURMOUNT-1, OASIS 4) in peer-reviewed sources.
What we didn't verify ⚠️
- ▸We didn't complete a Ro signup with a real account on this refresh cycle.
- ▸We didn't independently audit Ro's pharmacy partners or 503B inspections.
- ▸We didn't test the cancellation flow in real time.
Refresh cadence: Monthly through Q2 2026 (Foundayo and Wegovy HD are still rolling out and pricing may change), then quarterly. Spot something stale? Email corrections@therxindex.com and we'll update within 48 hours.
Frequently Asked Questions
Is Ro weight loss FDA approved?
Is Ro Body legit?
Does Ro prescribe compounded semaglutide for weight loss?
Is Ozempic through Ro FDA approved for weight loss?
How much does Ro weight loss cost in 2026?
Does Ro take insurance for GLP-1 medications?
Can I cancel Ro after the first month?
Is Wegovy HD available through Ro?
Is Foundayo available through Ro?
Is Ro the same as Hims for weight loss?
What's the difference between Ro and going directly to NovoCare or LillyDirect?
Bottom Line
Here's the clean summary:
- ▸Every medication on Ro's current Body weight-loss menu is FDA-approved. Wegovy (pen, HD pen, pill), Zepbound (pen, KwikPen, vials), and Foundayo are FDA-approved brand-name drugs sourced from Novo Nordisk and Eli Lilly's direct pharmacy partners. Ozempic is FDA-approved for diabetes and prescribed off-label for weight loss.
- ▸Ro was not on the FDA's March 3, 2026 list of 30 telehealth warning-letter recipients.
- ▸Real cost: $39 first month plus medication, then $149/mo (or $74/mo with annual prepay) plus medication. Cheapest all-in path starts at $188/mo first month for Wegovy pill or Foundayo, then $298–$448/mo ongoing.
- ▸Right call if you want FDA-approved brand-name GLP-1 through a managed program with insurance concierge support. Wrong call if you have Medicaid, want rock-bottom medication-only cost, or already have a doctor managing your treatment.
Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz →
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers. This page is for informational purposes and is not medical advice. GLP-1 medications require evaluation by a licensed healthcare provider. Pricing, medication availability, insurance support, and FDA status can change. We re-verify monthly through Q2 2026 and quarterly after.
Last updated: · Last verified: